{"id":"W2952212183","doi":"10.1183/23120541.00082-2019","title":"Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two<i>F508del</i>alleles","year":2019,"lang":"en","type":"article","venue":"ERJ Open Research","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital","funders":"ProQR Therapeutics; Einstein Stiftung Berlin; Bundesministerium für Bildung und Forschung; Arrowhead Pharmaceuticals; Vertex Pharmaceuticals; Genentech; AstraZeneca; PTC Therapeutics; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Gilead Sciences","keywords":"Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Medicine; Allele; Regulator; Gene; Mutation; Transmembrane protein; Ivacaftor; Genetics; Internal medicine; Receptor; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001740918,0.0005107457,0.001257847,0.0003338248,0.0003897945,0.0005794054,0.0005659466,0.001172817,0.005592709],"category_scores_gemma":[0.001096437,0.0002413906,0.001017224,0.0002348578,0.0006123302,0.0007347013,0.0005286857,0.001649218,0.00093646],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005527167,"about_ca_system_score_gemma":0.0007666006,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003471263,"about_ca_topic_score_gemma":0.001376397,"domain_scores_codex":[0.9993591,0.0002721427,0.00006003451,0.0001201949,0.00008045114,0.0001081207],"domain_scores_gemma":[0.9994048,0.0001331733,0.0001067519,0.00004396292,0.00006357827,0.0002477252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3121781,0.02030756,0.005928827,0.002449911,0.0008957363,0.0004335651,0.0003902691,0.001274511,0.09142717,0.001826643,0.007156797,0.5557309],"study_design_scores_gemma":[0.4025841,0.5183767,0.01619093,0.0004334383,0.0008219159,0.0008302176,0.0001739159,0.001101385,0.01253026,0.0009790624,0.04589968,0.00007830441],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9469572,0.01965462,0.004854596,0.002163219,0.000658401,0.01166301,0.00160528,0.0003547415,0.01208902],"genre_scores_gemma":[0.9677855,0.006723604,0.009102169,0.002190685,0.0002604186,0.008387938,0.00128517,0.00004212635,0.004222387],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005592709,"threshold_uncertainty_score":0.01870948,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.126589237287119,"score_gpt":0.4641736846248831,"score_spread":0.3375844473377642,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}